Aspirin + clopidogrel
- 1 lab in 1 country
- Funders: National Key Research and Development Program of China and 1 more
- Humans1
Outcomes
2Major bleeding
no changein humans1
1 study
Major bleeding
no changein humans1
Aspirin + clopidogrel has no effect on major bleeding in humans.
“without increasing in major bleeding.”
Humansin CAD patients with Class 1 multimorbidity pattern1-year
Impact of multimorbidity patterns on outcomes and treatment in patients with coronary artery disease
European heart journal open27 Mar 2024
Mortality
downin humans1HR 0.6
1 study
Mortality
downin humans1HR 0.6
Aspirin + clopidogrel decreases mortality in humans (adjusted HR 0.60, 95% CI 0.37-0.98).
“use of DAPT, particularly aspirin combined with clopidogrel, significantly reduced the 1-year all-cause mortality in Class 1 patients (adjusted HR 0.60, 95% CI 0.37-0.98, P = 0.04)”
Humansin CAD patients with Class 1 cardiovascular-kidney-metabolic comorbidities1-year
Impact of multimorbidity patterns on outcomes and treatment in patients with coronary artery disease
European heart journal open27 Mar 2024
Latest
1 in 12 monthsAAIC 2025 Abstract
Elevated Platelet Aggregation Associates with Increased Alzheimer's Disease Blood Biomarker Concentrations in Patients with Peripheral Artery Disease
Cohort study of 125 peopleMechanisms
European Heart Journal Open
Impact of multimorbidity patterns on outcomes and treatment in patients with coronary artery disease
Cohort study of 173,459 peopleMultimorbidity